Donald Kohn

Awards as PI
Award Value
Early Translational IV Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells $1,652,076
Disease Team Therapy Development III Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease $13,935,441
Disease Team Research I Stem Cell Gene Therapy for Sickle Cell Disease $8,834,129
Total:
$24,421,646.00
Videos